Christoph Salat

6.4k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Christoph Salat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Christoph Salat has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Hematology. Recurrent topics in Christoph Salat's work include Cancer Treatment and Pharmacology (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Platelet Disorders and Treatments (10 papers). Christoph Salat is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Platelet Disorders and Treatments (10 papers). Christoph Salat collaborates with scholars based in Germany, France and United States. Christoph Salat's co-authors include Rudolf Pihusch, Ernst Holler, Erhard Hiller, Hans‐Jochem Kolb, Rolf D. Issels, Sultan Abdel-Rahman, Wolfgang Hiddemann, Clemens‐Martin Wendtner, Lars H. Lindner and Ulrich Mansmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Christoph Salat

60 papers receiving 2.0k citations

Hit Papers

Neo-adjuvant chemotherapy... 2010 2026 2015 2020 2010 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
    2010 486 citations Rolf D. Issels, Lars H. Lindner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Salat Germany 22 564 540 470 346 346 63 2.0k
Torsten Keßler Germany 26 685 1.2× 529 1.0× 950 2.0× 305 0.9× 115 0.3× 92 2.1k
Markéta Jiroušková United States 18 582 1.0× 604 1.1× 352 0.7× 413 1.2× 102 0.3× 32 1.8k
Karl T. Beer Switzerland 16 795 1.4× 725 1.3× 614 1.3× 441 1.3× 126 0.4× 29 2.5k
Stefan Handt Germany 23 250 0.4× 315 0.6× 382 0.8× 673 1.9× 116 0.3× 60 2.0k
Christoph Mundhenke Germany 28 906 1.6× 124 0.2× 703 1.5× 403 1.2× 122 0.4× 106 2.3k
Conny J. van der Laken Netherlands 32 365 0.6× 311 0.6× 506 1.1× 318 0.9× 95 0.3× 100 2.8k
Susan Tannenbaum United States 20 194 0.3× 461 0.9× 345 0.7× 207 0.6× 501 1.4× 50 2.2k
Francisco Ayala Spain 24 774 1.4× 261 0.5× 492 1.0× 240 0.7× 61 0.2× 105 2.0k
M. Fevzi Özkaynak United States 19 783 1.4× 316 0.6× 854 1.8× 189 0.5× 54 0.2× 66 2.4k

Countries citing papers authored by Christoph Salat

Since Specialization
Citations

This map shows the geographic impact of Christoph Salat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Salat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Salat more than expected).

Fields of papers citing papers by Christoph Salat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Salat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Salat. The network helps show where Christoph Salat may publish in the future.

Co-authorship network of co-authors of Christoph Salat

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Salat. A scholar is included among the top collaborators of Christoph Salat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Salat. Christoph Salat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Stevic, Ines, Volkmar Müller, Karsten E. Weber, et al.. (2018). Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. BMC Medicine. 16(1). 179–179. 174 indexed citations
4.
Potthoff, Karin, Arnd Nusch, Ulrike Söling, et al.. (2016). Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: final results of the non-interventional study NABUCCO. Annals of Oncology. 27. vi72–vi72.
5.
6.
Sehouli, Jalid, Klaus Pietzner, Pauline Wimberger, et al.. (2014). Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study. Medical Oncology. 31(8). 76–76. 14 indexed citations
7.
Minckwitz, Gϋnter von, Eric Hahnen, Peter A. Fasching, et al.. (2014). Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.. Journal of Clinical Oncology. 32(15_suppl). 1005–1005. 39 indexed citations
8.
Papadimitriou, Christos, Tomasz Sarosiek, Joanna Pikiel, et al.. (2013). A phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for HER2 overexpressing metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 516–516. 5 indexed citations
9.
Stoetzer, Oliver J., Debora M.I. Fersching, Christoph Salat, et al.. (2013). Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin. Cancer Letters. 336(1). 140–148. 37 indexed citations
10.
Milani, Valeria, et al.. (2012). Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. International Journal of Hyperthermia. 29(1). 8–16. 35 indexed citations
11.
Hentrich, Marcus, Helmut Ostermann, Joachim Kienast, et al.. (2006). IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: A randomized, controlled, multiple-center trial*. Critical Care Medicine. 34(5). 1319–1325. 54 indexed citations
12.
Pihusch, Markus, Christoph Salat, Verena Pihusch, et al.. (2005). Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 36(7). 631–637. 10 indexed citations
13.
Pihusch, Markus, Christoph Salat, Verena Pihusch, et al.. (2005). Diagnosis of Hepatic Veno-occlusive Disease by Plasminogen Activator Inhibitor-1 Plasma Antigen Levels: A Prospective Analysis in 350 Allogeneic Hematopoietic Stem Cell Recipients. Transplantation. 80(10). 1376–1382. 28 indexed citations
14.
Pihusch, Rudolf, et al.. (2002). Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 81(8). 454–461. 20 indexed citations
15.
Pihusch, Rudolf, Christoph Salat, Markus Pihusch, et al.. (2002). Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 74(9). 1303–1309. 85 indexed citations
16.
Salat, Christoph, Ernst Holler, HJ Kolb, et al.. (1999). The Relevance of Plasminogen Activator Inhibitor 1 (PAI-1) as a Marker for the Diagnosis of Hepatic Veno-Occlusive Disease in Patients after Bone Marrow Transplantation. Leukemia & lymphoma. 33(1-2). 25–32. 21 indexed citations
17.
Salat, Christoph, Ernst Holler, H-J Kolb, et al.. (1997). Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplantation. 19(5). 487–490. 19 indexed citations
18.
Salat, Christoph, Peter Boekstegers, Ernst Holler, et al.. (1996). HEMOSTATIC PARAMETERS IN SEPSIS PATIENTS TREATED WITH ANTI-TNF±-MONOCLONAL ANTIBODIES. Shock. 6(4). 233–237. 14 indexed citations
19.
Salat, Christoph, et al.. (1994). [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].. PubMed. 89(5). 245–7. 4 indexed citations
20.
Gerl, A., et al.. (1993). Testicular cancer and Hodgkin disease in the same patient. Cancer. 71(9). 2838–2840. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Keßler Breakdown of academic impact, for papers by Markéta Jiroušková Breakdown of academic impact, for papers by Karl T. Beer Breakdown of academic impact, for papers by Stefan Handt Breakdown of academic impact, for papers by Christoph Mundhenke Breakdown of academic impact, for papers by Conny J. van der Laken Breakdown of academic impact, for papers by Susan Tannenbaum Breakdown of academic impact, for papers by Francisco Ayala Breakdown of academic impact, for papers by M. Fevzi Özkaynak
Rankless by CCL
2026